December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Human Trabecular Meshwork Cell Volume Regulation
Author Affiliations & Notes
  • JC Fleischhauer
    Dept of Physiology
    University of Pennsylvania Philadelphia PA
  • CH Mitchell
    Dept of Physiology
    University of Pennsylvania Philadelphia PA
  • DW Stamer
    Dept of Opthalmology University of Arizona Tucson AZ
  • K Peterson-Yantorno
    Dept of Physiology
    University of Pennsylvania Philadelphia PA
  • MM Civan
    Depts of Physiology and Medicine
    University of Pennsylvania Philadelphia PA
  • Footnotes
    Commercial Relationships   J.C. Fleischhauer, None; C.H. Mitchell, None; D.W. Stamer, None; K. Peterson-Yantorno, None; M.M. Civan, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1020. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      JC Fleischhauer, CH Mitchell, DW Stamer, K Peterson-Yantorno, MM Civan; Human Trabecular Meshwork Cell Volume Regulation . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1020.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To study the regulation of volume of trabecular meshwork (TM) cells, which may modify resistance to outflow of aqueous humor, thereby altering intraocular pressure. Methods: Volume, Cl- currents and intracellular Ca2+ activity of cultured human TM cells were studied with calcein fluorescence, whole-cell patch clamping and fura-2 fluorescence, respectively. Results: At physiologic HCO3- concentration, the selective Na+/H+ antiport inhibitor dimethylamiloride reduced isotonic cell volume. Hypotonicity triggered a regulatory volume decrease (RVD), which could be inhibited by the Cl- channel blocker 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB). The K+-Cl- symport blocker [(dihydro-indenyl)oxy]alkanoic acid (DIOA) also partially inhibited the RVD. Patch-clamp measurements showed that hypotonicity activated an outwardly-rectifying, NPPB-sensitive Cl- channel displaying the permeability ranking Cl- ≷ methylsulfonate ≷ aspartate. 2,3-Butanedione 2-monoxime (BDM) antagonizes actomyosin activity, and both increased baseline Ca2+ concentration and abolished the swelling-activated increase in Ca2+ concentration, but did not affect RVD. Conclusion: Human TM-cells display a Ca2+-independent RVD and their volume is regulated by swelling-activated Cl- channels, K+-Cl- symports and Na+/H+ antiports, in addition to the previously noted Na+-K+-2Cl- symport. This may account for the inability to lower intraocular pressure by blocking Na+-K+-2Cl- cotransport alone. [Support: Swiss National Science Foundation #1037 and Alfred Vogt Foundation, Switzerland Fellowships (JCF), an RPB Career Development Award (WDS), and NIH grants EY013624 (MMC), EY12797 (WDS), EY10009 (CHM), and EY01583 (CHM, MMC)]

Keywords: 445 ion channels • 601 trabecular meshwork • 324 aqueous 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×